At 4.1% CAGR, Middle East & Africa Organ Preservation Solution Market is Projected to be worth US$ 13,892.13 thousand by 2031, says Business Market Insights

According to Business Market Insights' research, the Middle East & Africa organ preservation solution market was valued at US$ 10,070.97 thousand in 2023 and is expected to reach US$ 13,892.13 thousand by 2031, registering a CAGR of 4.1% from 2023 to 2031. Rising need for organ transplantation and increasing prevalence of chronic diseases are among the critical factors attributed to drive the Middle East & Africa organ preservation solution market growth.

Several chronic diseases are known to damage the functioning of the heart, lungs, liver, kidney, and other organs. A poor diet contributes to the development of renal and hepatic illnesses, which can also lead to organ failure. For instance, around 10% of the global population is impacted by chronic kidney disease. Further, excessive alcohol consumption leads to liver cirrhosis, resulting in the need for a liver transplant. Transplantation surgeries are becoming more common worldwide. As of the end of 2023, more than 800 organ transplant procedures have been completed across Abu Dhabi healthcare facilities since the National Programme for Donation and Transplantation of Human Organs and Tissue, or Hayat, was introduced, according to the Department of Health - Abu Dhabi (DoH), which oversees the Emirate's healthcare system. Organ donations rose by 56% through the Hayat Programme, and organ transplants in Abu Dhabi saw a 36% increase in 2023 over the previous year. 422 kidney transplants, 259 liver transplants, 41 lung transplants, 22 heart transplants, 14 pancreas transplants, and 51 multi-organ transplants were performed in Abu Dhabi. Patients who are on the organ waiting list typically suffer from end-stage organ disease, which significantly affects their quality of life and may indicate that they are nearing the end of their life. The rising number of individuals with end-stage organ failure triggers the need for timely organ transplantation. Due to advancements in transplantation techniques, more such people are now eligible for organ transplants. Organ preservation solutions are used to maintain the viability and function of organs for a certain period, allowing for their transport and subsequent transplantation into a recipient. The success of organ transplantation is primarily determined by organ preservation, surgery, immunotherapy, and post-operative care. Thus, a rising demand for organ transplantation drives the organ preservation solution market toward growth.

On the contrary, the expensive organ transplant surgeries hamper the growth of Middle East & Africa organ preservation solution market.

Based on product, the Middle East & Africa organ preservation solution market is categorized into University of Wisconsin solution, custodiol HTK, Perfadex, Hypothermosol, and others. The University of Wisconsin segment held 41.1% market share in 2023, amassing US$ 4,138.80 thousand. It is projected to garner US$ 5,795.15 thousand by 2031 to register 4.3% CAGR during 2023-2031.

In terms of application, the Middle East & Africa organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held 45.7% share of Middle East & Africa organ preservation solution market in 2023, amassing US$ 4,606.36 thousand. It is anticipated to garner US$ 6,455.67 thousand by 2031 to expand at 4.3% CAGR during 2023-2031.

By type, the Middle East & Africa organ preservation solution market is categorized into kidneys, liver, lungs, heart, and others. The kidneys segment held 59.2% share of Middle East & Africa organ preservation solution market in 2023, amassing US$ 5,960.28 thousand. It is projected to garner US$ 8,347.52 thousand by 2031 to expand at 4.3% CAGR from 2023 to 2031.

Based on end user, the Middle East & Africa organ preservation solution market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held 57.0% share of Middle East & Africa organ preservation solution market in 2023, amassing US$ 5,739.18 thousand. It is predicted to garner US$ 8,073.20 thousand by 2031 to expand at 4.4% CAGR between 2023 and 2031.

Based on country, the Middle East & Africa organ preservation solution market is categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 46.2% share of Middle East & Africa organ preservation solution market in 2023. It was assessed at US$ 4,649.77 thousand in 2023 and is likely to hit US$ 6,336.20 thousand by 2031, registering a CAGR of 4.0% during 2023-2031.

Key players operating in the Middle East & Africa organ preservation solution market are XVIVO Perfusion, TransMedics, Dr. Franz Koehler Chemie GmbH, and Accord Healthcare, among others.

• In June 2019, TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations of Cold Storage.
• In April 2018, TransMedics, Inc. Received FDA Pre-Market Approval (PMA) for its OCS Lung System for Near-Physiologic Preservation and Assessment of Lungs for Transplantation.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com